Title : Ospemifene for the treatment of postmenopausal vulvar and vaginal atrophy: recommendations for clinical use.

Pub. Date : 2015

PMID : 26634778






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ospemifene is a nonhormonal, estrogen receptor agonist/antagonist (ERAA) FDA-approved for the treatment of moderate to severe dyspareunia, a symptom of VVA, due to menopause. Ospemifene estrogen receptor 1 Homo sapiens